Aska PharmaceuticalLtd. (ASKPF) Q2 2026 Earnings

11MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
0.23
0.28
0.33
0.38

Details

Expected EPS
N/A
Actual EPS
0.33713194
Surprise EPS
0.34
Surprise Percent
+∞%

Description

Aska PharmaceuticalLtd. (ASKPF) has reported earnings of 0.33713194 per share for Q2 2026.

0 Comments

Share your thoughts